In-utero exposure to metformin for type 2 diabetes or polycystic ovary syndrome: A prospective comparative observational study
ConclusionMetformin-T1-exposure per se is not associated with an increased risk of major anomalies.
Source: Reproductive Toxicology - Category: Toxicology Source Type: research
More News: Cardiology | Cardiovascular | Cesarean Section | Diabetes | Diabetes Type 2 | Endocrinology | Fortamet | Genetics | Heart | Insulin | Israel Health | Metformin | Ovaries | Polycystic Ovary Syndrome | Study | Toxicology | Women